Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17610495 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPTPPARGMEN1KMT2A | |
| SCHEMBL198654 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPTPPARGMEN1KMT2A | |
| Water SCHEMBL28484737 | 0.98 | ALDH1A1 (0.33) | ALDH1A1MAPTPPARG | |
| Hydrochloric Acid SCHEMBL28132975 | 0.98 | ALDH1A1 (0.35) | ALDH1A1MAPTPPARGMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL17293302 | 0.97 | ALDH1A1 (0.35) | ALDH1A1MAPTPPARGMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL19065058 | 0.97 | ALDH1A1 (0.35) | ALDH1A1MAPTPPARGMEN1KMT2A | |
| Sulfurous Acid SCHEMBL28518724 | 0.94 | PPARG (0.31) | ALDH1A1MAPTPPARG | |
| SCHEMBL28518721 | 0.90 | PPARG (0.31) | PPARG | |
| Imidazole SCHEMBL29264303 | 0.89 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9780515 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122063204-A | High performance liquid chromatography detection method for ergothioneine | 弈柯莱生物科技(集团)股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| EP-4520819-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-118271245-A | Synthesis method of ergothioneine | 深圳瑞德林生物技术有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118256457-A | Synthesis method of ergothioneine | 深圳瑞德林生物技术有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118256455-A | Method for preparing ergothioneine by directly utilizing cysteine | 深圳瑞德林生物技术有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-117083377-B | Chemo-enzyme coupling method for synthesizing ergothioneine | 中国科学院上海有机化学研究所 | 2024-04-26 | — | — | CN | claimed |
| CN-115301218-B | Lignocellulose sponge-based waste gas adsorption material and application thereof | 江苏宿迁润泰环保科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20240036055-A1 | Multiplexed DiLeu-Biotin-Azide (DBA) Tag Enabled Isobaric Tandem Orthogonal Proteolysis Activity-Based Protein Profiling (isoBOP-ABPP) Platform For High-Throughput Quantitative Pan-PTM Analysis | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-20160244484-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2016-08-25 | — | — | US | claimed |
| EP-3049428-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) | 2016-08-03 | — | — | EP | claimed |
| WO-2015181507-A1 | NOVEL COMPOUNDS OF THE 5-ACYLSULFANYL-HISTIDINE TYPE AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THE DISULFIDES THEREOF | TETRAHEDRON (FR) | 2015-12-03 | — | — | WO | claimed |
| WO-2015040235-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2015-03-26 | — | — | WO | claimed |
| EP-2471810-A1 | Oxyntomodulin derivatives | Merck Sharp & Dohme Corporation (US) | 2012-07-04 | — | — | EP | claimed |
| US-20110183902-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OXYNTOMODULIN DERIVATIVES AND A METHOD FOR REDUCING BODY WEIGHT USING THE COMPOSITION | MERCK SHARP & DOHME CORP. (US) | 2011-07-28 | — | — | US | claimed |
| US-20100144617-A1 | Oxyntomodulin Derivatives | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | claimed |
| US-20100143322-A1 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | PLT PATENT & LICENCE TRADING LTD., C/O THE B-NET (GB) | 2010-06-10 | — | — | US | claimed |
| EP-1991574-A2 | OXYNTOMODULIN DERIVATIVES | Merck & Co., Inc. (US) | 2008-11-19 | — | — | EP | claimed |
| WO-2007100535-A2 | OXYNTOMODULIN DERIVATIVES | MERCK & CO., INC. (US) | 2007-09-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144617-A1 | Oxyntomodulin Derivatives | GPR119, OGFRL1, OGFR | ALDH1A1 2554/4885MAPT 2525/4885PPARG 169/4885 |
| US-20160244484-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | VIP, TNF, ENPEP | ALDH1A1 2456/4885MAPT 3805/4885PPARG 1953/4885 |
| US-20110183902-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OXYNTOMODULIN DERIVATIVES AND A METHOD FOR REDUCING BODY WEIGHT USING THE COMPOSITION | OGFR, GPR119, THOP1 | ALDH1A1 3545/4885MAPT 2122/4885PPARG 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.